Tempus AI stock sinks following Spruce Point short report

Published 28/05/2025, 14:26
© Reuters.

Investing.com -- Shares of Tempus AI (NASDAQ: TEM) tumbled 4% after the company was targeted in a short-seller report by Spruce Point. The report raised serious concerns about the integrity of Tempus AI’s product, the credibility of its management, and its financial reporting practices.

The Spruce Point report, which follows a forensic review of the precision medicine solutions company, criticized Tempus AI for the minimal revenue generated from its AI Applications product line, suggesting a disconnect between the company’s branding and its financial reality. In 2024, AI-related revenue was reported to be just $12.4 million, less than 2% of the company’s total revenue of $693.4 million. The prior year, AI revenue was only $5.5 million.

Moreover, the report highlighted concerns over Tempus AI’s leadership, noting CEO Eric Lefkofsky’s history with companies that experienced financial scandals, including bankruptcies and restatements. It also questioned the company’s partnerships and joint ventures, suggesting potential round-tripped sales and related party deals.

The report further scrutinized Tempus AI’s billing practices, indicating aggressive use of billing code 81479, known for minimal oversight and a high risk of abuse. This tactic could inflate revenue at the expense of patient care, with the report suggesting that Tempus AI and its acquired entity, Ambry, may prioritize revenue over clinical necessity.

In conclusion, Spruce Point warned investors of the company’s reliance on perceived equity value, aggressive accounting, and unsustainable practices. They projected a 50% – 60% potential downside risk to Tempus AI’s share price, advising extreme caution and close scrutiny of the company’s public statements. The sell-side consensus price target stands at $66.82 per share, which implies a mere 1% upside potential.

Investors reacted to the report by selling off shares, reflecting the market’s concern over the allegations made by Spruce Point. 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.